HomeCompareCMXC vs PEP

CMXC vs PEP: Dividend Comparison 2026

CMXC yields 470.59% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CMXC wins by $38544.98M in total portfolio value
10 years
CMXC
CMXC
● Live price
470.59%
Share price
$0.43
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38545.12M
Annual income
$27,182,357,871.92
Full CMXC calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — CMXC vs PEP

📍 CMXC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMXCPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CMXC + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CMXC pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMXC
Annual income on $10K today (after 15% tax)
$40,000.00/yr
After 10yr DRIP, annual income (after tax)
$23,105,004,191.13/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, CMXC beats the other by $23,104,951,596.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMXC + PEP for your $10,000?

CMXC: 50%PEP: 50%
100% PEP50/50100% CMXC
Portfolio after 10yr
$19272.63M
Annual income
$13,591,209,873.80/yr
Blended yield
70.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

CMXC
No analyst data
Altman Z
-276.8
Piotroski
3/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMXC buys
0
PEP buys
0
No recent congressional trades found for CMXC or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMXCPEP
Forward yield470.59%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$38545.12M$141.9K
Annual income after 10y$27,182,357,871.92$61,875.67
Total dividends collected$37542.88M$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: CMXC vs PEP ($10,000, DRIP)

YearCMXC PortfolioCMXC Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$57,759$47,058.82$10,849$509.42+$46.9KCMXC
2$315,826$254,024.51$11,969$750.47+$303.9KCMXC
3$1,636,076$1,298,141.44$13,500$1,124.14+$1.62MCMXC
4$8,035,425$6,284,824.27$15,680$1,721.66+$8.02MCMXC
5$37,445,846$28,847,941.19$18,929$2,715.34+$37.43MCMXC
6$165,706,448$125,639,392.36$24,023$4,450.80+$165.68MCMXC
7$696,916,266$519,610,366.98$32,510$7,669.92+$696.88MCMXC
8$2,788,074,169$2,042,373,764.24$47,709$14,093.60+$2788.03MCMXC
9$10,619,401,952$7,636,162,591.12$77,415$28,083.48+$10619.32MCMXC
10$38,545,117,961$27,182,357,871.92$141,922$61,875.67+$38544.98MCMXC

CMXC vs PEP: Complete Analysis 2026

CMXCStock

Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada.

Full CMXC Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this CMXC vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMXC vs SCHDCMXC vs JEPICMXC vs OCMXC vs KOCMXC vs MAINCMXC vs MOCMXC vs PMCMXC vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.